Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-10

Clinical Trial Update: HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated [NA]

View source ↗

Summary

A completed clinical trial update describes HBsAg clearance in inactive carriers of chronic hepatitis B who were previously treated with interferon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon (interferon)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | NA | Status: COMPLETED